Metabolic syndrome and the risk of calcium stones

Nephrology Dialysis Transplantation

Volumn 27, Issue 8, 2012, Pages 3201-3209

  Sakhaee, Khashayar ^a,b   Capolongo, Giovanna ^a   Maalouf, Naim M ^a,b   Pasch, Andreas ^c   Moe, Orson W ^a,b   Poindexter, John ^b   Adams Huet, Beverley ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

kidney stone; metabolic syndrome; nephrolithiasis; obesity

Indexed keywords

CALCIUM OXALATE;

ADULT; ANTHROPOMETRY; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM STONE; CALCIUM URINE LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; URINALYSIS;

ADULT; AGED; CALCIUM; CALCIUM OXALATE; COHORT STUDIES; FEMALE; HUMANS; KIDNEY CALCULI; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SWITZERLAND; TEXAS;

EID: 84864624241     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr703     Document Type: Article

References (42)

1. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004; 27: 2444-2449.
2. Flegal KM, Carroll MD, Ogden CL et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
3. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
4. West B, Luke A, Durazo-Arvizu RA et al. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis 2008; 51: 741-747.
5. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA 2005; 293: 455-462.
6. Sakhaee K, Adams-Huet B, Moe OW et al. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 2002; 62: 971-979.
7. Abate N, Chandalia M, Cabo-Chan AV, Jr et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 2004; 65: 386-392.
8. Cameron MA, Maalouf NM, Adams-Huet B et al. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 2006; 17: 1422-1428.
9. Maalouf NM, Cameron MA, Moe OWet al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2007; 2: 883-888.
10. Maalouf NM, Cameron MA, Moe OWet al. Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol 2010; 5: 1277-1281.
11. Daudon M, Traxer O, Conort P et al. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 2006; 17: 2026-2033.
12. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992; 327: 1141-1152.
13. Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995; 98: 50-59.
14. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among U.S. adults. Obes Res 2003; 11: 1223-1231.
15. Sundstrom J, Riserus U, Byberg L et al. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 2006; 332: 878-882.
16. Malik S, Wong ND, Franklin SS et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250.
17. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2192.
18. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495.
19. Kok DJ, Poindexter J, Pak CY. Calculation of titratable acidity from urinary stone risk factors. Kidney Int 1993; 44: 120-126.
20. Rodgers A, Allie-Hamdulay S, Jackson G. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor. Nephrol Dial Transplant 2006; 21: 361-369.
21. Taylor EN, Curhan GC. Demographic, dietary, and urinary factors and 24-h urinary calcium excretion. Clin J Am Soc Nephrol 2009; 4: 1980-1987.
22. Frumar AM, Meldrum DR, Geola F et al. Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. J Clin Endocrinol Metab 1980; 50: 70-75.
23. Heller HJ, Sakhaee K, Moe OW et al. Etiological role of estrogen status in renal stone formation. J Urol 2002; 168: 1923-1927.
24. Sakhaee K, Harvey JA, Padalino PK et al. The potential role of salt abuse on the risk for kidney stone formation. J Urol 1993; 150(2 Pt 1): 310-312.
25. Lemann J, Litzow JR, Lennon EJ. Studies of the mechanism by which chronic metabolic acidosis augments urinary calcium excretion in man. J Clin Invest 1967; 46: 1318-1328.
26. Breslau NA, Brinkley L, Hill KD et al. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 1988; 66: 140-146.
27. Borghi L, Schianchi T, Meschi T et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002; 346: 77-84.
28. Brannan PG, Vergne-Marini P, Pak CY et al. Magnesium absorption in the human small intestine. Results in normal subjects, patients with chronic renal disease, and patients with absorptive hypercalciuria. J Clin Invest 1976; 57: 1412-1418.
29. Broadus AE, Dominguez M, Bartter FC. Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups. J Clin Endocrinol Metab 1978; 47: 751-760.
30. Brannan PG, Morawski S, Pak CY et al. Selective jejunal hyperabsorption of calcium in absorptive hypercalciuria. Am J Med 1979; 66: 425-428.
31. Coe FL, Favus MJ, Crockett T et al. Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH) 2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 1982; 72: 25-32.
32. Maalouf NM, Sakhaee K, Parks JH et al. Association of urinary pH with body weight in nephrolithiasis. Kidney Int 2004; 65: 1422-1425.
33. Bobulescu IA, Dubree M, Zhang J et al. Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Am J Physiol Renal Physiol 2008; 294: F1315-F1322.
34. Bobulescu IA, Dubree M, Zhang J et al. Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification. Am J Physiol Renal Physiol 2009; 297: F1419-F1426.
35. Curhan GC, Willett WC, Rimm EB et al. Body size and risk of kidney stones. J Am Soc Nephrol 1998; 9: 1645-1652.
36. Daudon M, Lacour B, Jungers P. High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant 2005; 20: 468-469.
37. DeFronzo RA, Cooke CR, Andres R et al. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975; 55: 845-855.
38. Kerstetter J, Caballero B, O'Brien K et al. Mineral homeostasis in obesity: effects of euglycemic hyperinsulinemia. Metabolism 1991; 40: 707-713.
39. Pitroda AP, Harris SS, Dawson-Hughes B. The association of adiposity with parathyroid hormone in healthy older adults. Endocrine 2009; 36: 218-223.
40. Bell NH, Epstein S, Greene A et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76: 370-373.
41. Lemann J, Jr, Pleuss JA,Worcester EM et al. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int 1996; 49: 200-208.
42. Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 1997; 51: 894-900